BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Donato M, Ostacolo C, Giovannelli P, Di Sarno V, Monterrey IMG, Campiglia P, Migliaccio A, Bertamino A, Castoria G. Therapeutic potential of TRPM8 antagonists in prostate cancer. Sci Rep 2021;11:23232. [PMID: 34853378 DOI: 10.1038/s41598-021-02675-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sakellakis M, Chalkias A. The Role οf Ion Channels in the Development and Progression of Prostate Cancer. Mol Diagn Ther 2023. [PMID: 36600143 DOI: 10.1007/s40291-022-00636-9] [Reference Citation Analysis]
2 Ertl IE, Brettner R, Kronabitter H, Mohr T, Derdak S, Jeitler M, Bilban M, Garstka N, Shariat SF. The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer. Cells 2022;12. [PMID: 36611918 DOI: 10.3390/cells12010124] [Reference Citation Analysis]
3 Mendonça CCR, Viana JO, Jordão AK, Barbosa E. Employing QSAR to design synthetic accessible TRPM8 Inhibitors.. [DOI: 10.21203/rs.3.rs-2371227/v1] [Reference Citation Analysis]
4 He M, Wu G, Wang Z, Ren K, Yang Z, Xue Q. Development and validation of a TRP-related gene signature for overall survival prediction in lung adenocarcinoma. Front Genet 2022;13:905650. [DOI: 10.3389/fgene.2022.905650] [Reference Citation Analysis]
5 Di Sarno V, Giovannelli P, Medina-peris A, Ciaglia T, Di Donato M, Musella S, Lauro G, Vestuto V, Smaldone G, Di Matteo F, Bifulco G, Castoria G, Migliaccio A, Fernandez-carvajal A, Campiglia P, Gomez-monterrey I, Ostacolo C, Bertamino A. New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. European Journal of Medicinal Chemistry 2022;238:114435. [DOI: 10.1016/j.ejmech.2022.114435] [Reference Citation Analysis]
6 Xie B, Meng Q, Yu H, Shen K, Cheng Y, Dong C, Zhou H. Estrogen receptor β-targeted hypoxia-responsive near-infrared fluorescence probes for prostate cancer study. European Journal of Medicinal Chemistry 2022;238:114506. [DOI: 10.1016/j.ejmech.2022.114506] [Reference Citation Analysis]
7 Zhang X, He Y, Ren P, Chen L, Han Z, Qi L, Chen L, Luo Y, Zhang N, Lu W, Guo H. Low expression and Hypermethylation of ATP2B1 in Intrahepatic Cholangiocarcinoma Correlated With Cold Tumor Microenvironment. Front Oncol 2022;12:927298. [DOI: 10.3389/fonc.2022.927298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu G, He M, Yin X, Wang W, Zhou J, Ren K, Chen X, Xue Q. The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response. Front Immunol 2022;13:837665. [PMID: 35493463 DOI: 10.3389/fimmu.2022.837665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Iraci N, Ostacolo C, Medina-peris A, Ciaglia T, Novoselov AM, Altieri A, Cabañero D, Fernandez-carvajal A, Campiglia P, Gomez-monterrey I, Bertamino A, Kurkin AV. In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening. IJMS 2022;23:2070. [DOI: 10.3390/ijms23042070] [Reference Citation Analysis]
10 Licitra F, Giovannelli P, Di Donato M, Monaco A, Galasso G, Migliaccio A, Castoria G. New Insights and Emerging Therapeutic Approaches in Prostate Cancer. Front Endocrinol 2022;13:840787. [DOI: 10.3389/fendo.2022.840787] [Reference Citation Analysis]
11 Di Donato M, Giovannelli P, Barone MV, Auricchio F, Castoria G, Migliaccio A. A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells. Cells 2021;11:14. [PMID: 35011576 DOI: 10.3390/cells11010014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]